Hospital-acquired Infection Control Market is projected to increase at a CAGR of around 7% from 2023 to 2033

The Hospital-acquired Infection Control Market revenue were estimated at US$ 6.1 Billion in 2022 and is anticipated to grow at a CAGR of 7% from 2023 to 2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 12.7 Billion.

The frequent occurrence of hospital-acquired infections, the growing proportion of surgical procedures, the rising geriatric population and the increasing prevalence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental and personal hygiene are the key factors driving the growth of the Hospital-acquired infection control market.

Get Sample PDF@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16573

The growing use of e-beam sterilization and the reintroduction of ethylene oxide sterilization are further expected to swell the demand for hospital-acquired infection control.

The percentage of surgeries performed worldwide has increased significantly over the years. Every year, approximately 235 million complex surgical procedures are performed worldwide, according to the WHO. This is due to an increase in the prevalence of obesity and other lifestyle diseases, an increase in the geriatric population, and an increase in the incidence of spinal injuries and sports-related injuries.

With the growth in the number of surgical procedures conducted, the demand for various surgical equipment and medical devices is also surging. The proven benefits of sterilized product lines and growing awareness about their effectiveness in healthcare settings are expected to drive demand for hospital-acquired infection services.

Due to rising demand for Hospital-acquired Infection Control methods in developing nations, particularly Japan, the market in the Asia Pacific is projected to account for a CAGR of over 7% during the forecast period.

The regional market is growing due to the extensive usage of Hospital-acquired infection controls and increased awareness of general health and fitness among the working-class population.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16573

Competitive Analysis

The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.

Some of the recent developments of key Hospital-acquired Infection Control providers are as follows:

  • In 2021, STERIS purchased Cantel, a global provider of infection control products and services, through a U.S. subsidiary to broaden its vast array of sterilization services.
  • In 2021, Sterigenics S.A.S., a Sotera Health Company subsidiary, increased its European sterilizing capacity by expanding its ethylene oxide factory in Rantigny, France. Getinge introduced the Getinge Solsus 66 steam sterilizer for hospitals as well as surgical instruments in 2020, which has a higher capacity and operational reliability than other sterilizers.
  • In 2020, Sotera Health Company acquired Iotron, a prominent North American outsourced provider of E-beam sterilization services. The acquisition was intended to help the company expand its electron beam footprint and boost sales of the Sterigenics division.

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Hospital-acquired Infection Control Market, presenting historical market data (2018 to 2022) and forecast statistics for the period of 2023 to 2033.

Buy Now@ https://www.futuremarketinsights.com/checkout/16573

Market Segments Covered in Hospital-acquired Infection Control Industry Analysis

By Component:

  • Equipment
  • Sterilization Equipment
  • Disinfection Equipment
  • Consumables
  • Disinfectants
  • Sterilization Consumables
  • Others (Waste Disposal, PPE)
  • Services

By End-user:

  • Hospitals and Intensive Care Units
  • Ambulatory Surgical and Diagnostic Centers
  • Other End-users

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these